Literature DB >> 23960676

Waiting time for transfer of patients with prostaglandin dependant congenital heart defects to tertiary cardiac centers.

Abdul Rahman Al Mesned1, Ali A Al Akhfash, Maha Sayed.   

Abstract

UNLABELLED: Worldwide congenital heart defects (CHD) are the leading cause of infant deaths owing to congenital anomalies. Delay in diagnosing and operating in neonates with prostaglandin dependant CHD may lead to significant morbidity and mortality.
OBJECTIVES: To assess the time interval needed for acceptance and transfer of patients with critical CHD to a tertiary cardiac center and the impact on the patient's survival. STUDY
DESIGN: Retrospective database reviews of all cases diagnosed to have prostaglandin dependant (PG) CHD at Prince Sultan Cardiac Center-Qassim during a 43 months period (from May 2007 to December 2010).
RESULTS: During the study period 104 patients were diagnosed to have PG dependant CHD. Patients with PG dependant systemic circulation constitute 60% of patients. Patients with ventricular septal defect (VSD) associated with coarctation of the aorta constituted 16% of patients. The mean waiting time for transfer to a tertiary cardiac center was 10 ± 10 days. Twenty-two (21%) patients died while waiting for acceptance and transfer. Eleven patients were diagnosed with hypoplastic left heart syndrome (HLHS). There was no significant difference in the waiting time for those with or without HLHS, with a mean of 9 days for both. Six of our patients had infections with positive blood cultures. The mean waiting period for those with proved infection was 25 days compared with 8 days for those with no proved infection (p value < 0.005).
CONCLUSION: There are a significant number of patients with severe CHD who die while waiting for acceptance and transfer to a tertiary cardiac center. The causes for delay could be the presence of infection, prematurity and low birth weight. The limited numbers of tertiary cardiac centers in Saudi Arabia as well as cardiac ICU beds are among the factors delaying the acceptance of patients requiring cardiac surgery.

Entities:  

Keywords:  Prince Sultan Cardiac Center-Qassim; Prostaglandin dependant congenital heart defects; Waiting time

Year:  2011        PMID: 23960676      PMCID: PMC3727379          DOI: 10.1016/j.jsha.2011.10.004

Source DB:  PubMed          Journal:  J Saudi Heart Assoc        ISSN: 1016-7315


  6 in total

1.  Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997.

Authors:  R S Boneva; L D Botto; C A Moore; Q Yang; A Correa; J D Erickson
Journal:  Circulation       Date:  2001-05-15       Impact factor: 29.690

Review 2.  Measuring the global burden of disease and epidemiological transitions: 2002-2030.

Authors:  A D Lopez; C D Mathers
Journal:  Ann Trop Med Parasitol       Date:  2006 Jul-Sep

3.  Congenital heart disease in 56,109 births. Incidence and natural history.

Authors:  S C Mitchell; S B Korones; H W Berendes
Journal:  Circulation       Date:  1971-03       Impact factor: 29.690

4.  Infant mortality and congenital anomalies from 1950 to 1994: an international perspective.

Authors:  A Rosano; L D Botto; B Botting; P Mastroiacovo
Journal:  J Epidemiol Community Health       Date:  2000-09       Impact factor: 3.710

5.  Outcome of Norwood and Damus-Kaye-Stansel procedures for univentricular congenital heart anomalies.

Authors:  Ali A Al-Akhfash; Mohamed S Kabbani; Riyadh M Abu-Sulaiman; Omar R Tamimi; Mahmoud A Elbarbary; Hani K Najm
Journal:  Saudi Med J       Date:  2009-03       Impact factor: 1.484

6.  Nomenclature and classification of congenital heart disease.

Authors:  M J Tynan; A E Becker; F J Macartney; M Q Jiménez; E A Shinebourne; R H Anderson
Journal:  Br Heart J       Date:  1979-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.